Back to Search
Start Over
Antiemetic efficacy of granisetron in patients with gynecological malignancies
- Source :
- Anti-Cancer Drugs. 8:225-230
- Publication Year :
- 1997
- Publisher :
- Ovid Technologies (Wolters Kluwer Health), 1997.
-
Abstract
- The efficacy and tolerability of granisetron in the management of acute and delayed emesis was compared with that of a multiple antiemetic drug combination regimen, including metoclopramide, dexamethasone, lorazepam and orphenadrine. The trial was a randomized, cross-over study involving 111 patients with gynecological cancers undergoing chemotherapy with cisplatin. Granisetron was significantly more effective than the combination regimen during the first 24 h after chemotherapy; complete response, rates were 67 and 48%, respectively (p = 0.002). There was a significant reduction in the effectiveness of the combination during the second treatment cycle, compared with the first. In contrast, the efficacy of granisetron did not differ between the two cycles. The response rate during the 6 days after chemotherapy was 40.8% in both groups. At the end of the study, 55% of patients preferred granisetron and 23% preferred the combination (p < 0.001). Granisetron was well tolerated. The principal adverse event was headache, which was reported in 7% of patients. The results of this study confirm that granisetron is effective in the treatment of cisplatin-induced nausea and vomiting during the 24 h after chemotherapy.
- Subjects :
- Adult
Cancer Research
medicine.medical_specialty
Metoclopramide
Genital Neoplasms, Female
Vomiting
medicine.drug_class
Nausea
medicine.medical_treatment
Antineoplastic Agents
Granisetron
Gastroenterology
Antineoplastic Agent
Internal medicine
Humans
Medicine
Antiemetic
Single-Blind Method
Pharmacology (medical)
Aged
Pharmacology
Chemotherapy
Cross-Over Studies
business.industry
Cross-Over Studie
Middle Aged
Regimen
Treatment Outcome
Oncology
Tolerability
MED/06 - ONCOLOGIA MEDICA
Antiemetics
Female
Cisplatin
medicine.symptom
business
Human
medicine.drug
Subjects
Details
- ISSN :
- 09594973
- Volume :
- 8
- Database :
- OpenAIRE
- Journal :
- Anti-Cancer Drugs
- Accession number :
- edsair.doi.dedup.....ed8275a0d7f3fe82ded4e8eb3274e2aa